CMPX
Compass Therapeutics, Inc.
$2.34
+0.02 (+0.86%)
At close · Jul 8
Market Cap
$416.00M
Shares
180,087,915
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
-100%
FY2025
Net Income
-$66.49M
-34.7%
FY2025
Operating Margin
-6661.76%
FY2024
Operating Cash Flow
-$49.14M
-9.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| — | $0 | $850K | $0 | — | — | — | — | |
| $56.31M | $55.97M | $42.34M | $38.12M | $30M | $20.34M | $14.9M | $22.45M | |
| $18.87M | $16.87M | $15.13M | $12.24M | $11.66M | $10.93M | $12.91M | $11.6M | |
| — | $276K | $589K | $699K | $782K | $600K | $2.4M | $2.1M | |
| $75.17M | $72.84M | $57.48M | $50.36M | $41.66M | $81.88M | $27.81M | $34.05M | |
| -$75.17M | -$72.84M | -$56.63M | -$50.36M | -$41.66M | -$81.88M | -$27.81M | -$34.05M | |
| — | — | -6661.76% | — | — | — | — | — | |
| — | -$72.56M | -$56.04M | -$49.66M | -$40.87M | -$81.28M | -$25.41M | -$31.95M | |
| — | — | — | — | $0 | $370K | $908K | $1.23M | |
| — | $6.4M | $7.3M | $7.9M | $2.36M | $29K | $88K | $743K | |
| $7M | $6.35M | $7.25M | $7.87M | $2.43M | -$299K | -$1.66M | -$601K | |
| — | — | — | -$42.49M | -$39.23M | -$82.18M | -$29.47M | -$34.65M | |
| — | $0 | $0 | $0 | $0 | $0 | $32K | $91K | |
| -$68.17M | -$66.49M | -$49.38M | -$42.49M | -$39.23M | -$82.18M | -$29.5M | -$34.74M | |
| — | — | -5808.82% | — | — | — | — | — | |
| -$68.52M | -$66.42M | -$49.2M | -$42.16M | -$39.53M | -$82.18M | — | — | |
| USD/shares | — | -$0.42 | -$0.36 | -$0.33 | -$0.37 | -$1.31 | — | — |
| shares | — | 157.7M | 137.38M | 127.03M | 105.19M | 62.87M | 30.78M | 6.69M |
| shares | — | — | 137.4M | — | — | 62.87M | 30.78M | 6.69M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
—
Biotechnology median 7.68×